Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Stroke Prevention in Atrial Fibrillation Trial Populations
| Trial Characteristics | Dabigatran (RE‐LY)23 | Rivaroxaban (ROCKET AF)24 | Apixaban (ARISTOTLE)25 |
|---|---|---|---|
| Participants, n | 18 113 | 14 264 | 18 201 |
| Median age | 71 (mean) | 73 | 70 |
| Mean CHADS2 | 2.1 | 3.5 | 2.1 |
| Mean TTR | 64% | 55% | 62% |
| Median CrCl | 68 | 67 | N/A* |
CrCl indicates creatinine clearance; CHADS2, congestive heart failure, hypertension, age, diabetes, stroke; TTR, time in therapeutic range.
Data on renal function presented as 83% with CrCl ≥50 mL/min.
